Results are expressed as number of patients treated with intravenous thrombolysis within 60 minutes of symptom onset divided by number of patients treated with intravenous thrombolysis in each treatment group. The test for heterogeneity between subgroups was P = .08. NA indicates not applicable.
aPreviously unpublished (disentangled) data, excluding patients with stroke mimic in the study by Larsen et al.16 When including patients with stroke mimic, the crude OR for golden-hour thrombolysis in the study by Larsen et al16 was 4.62 (95% CI, 1.46-14.59). Furthermore, there was partial overlap in participants between the studies by Ebinger et al,36 Kunz et al,37 and Nolte et al.42